Siglece
M. musculus
sialic acid binding Ig-like lectin E
What the model saw
Gene: Siglece Organism: Mus musculus Known functions: sialic acid binding Ig-like lectin E. sialic acid-binding Ig-like lectin 12. monosaccharide binding. protein binding. sialic acid binding.
View unredacted entry
sialic acid binding Ig-like lectin E. sialic acid-binding Ig-like lectin 12. monosaccharide binding. protein binding. sialic acid binding.
Solver output
Siglec-E (Siglece) is an inhibitory receptor on innate immune cells (particularly neutrophils and macrophages) that binds sialic acid-containing glycans and delivers immunosuppressive signals via ITIMs. While this dampens acute inflammatory responses, Siglec-E's normal function suppresses immune surveillance and anti-pathogen responses, and its sialic acid-binding activity is exploited by tumors and pathogens to evade immune clearance. In the context of aging, chronic low-grade inflammation (inflammaging) is a hallmark, and Siglec-E's inhibitory role on innate immune cells can impair the clearance of senescent cells and damaged cellular debris, thereby permitting accumulation of pro-aging signals. Loss of Siglec-E function in mice has been associated with enhanced immune activation, suggesting its normal function restrains beneficial immune responses needed for tissue homeostasis in aging. Thus, the normal pro-inhibitory function of Siglec-E is predicted to be anti-longevity by blunting immune clearance mechanisms that counteract inflammaging and cellular senescence.
GenAge curators classify each gene's normal function as promoting (Pro-Longevity) or opposing (Anti-Longevity) longevity, based on synthesis across studies. Loss-of-function effects can vary from this depending on the manipulation.
Advisor judgment
The model predicted anti_longevity while the ground truth is pro_longevity. The model's reasoning is internally consistent but leads to the wrong conclusion. Siglec-E is an inhibitory immune receptor, and the model argues that its immunosuppressive function impairs clearance of senescent cells and damaged debris, making it anti-longevity. However, the ground truth indicates Siglec-E is pro-longevity, likely because its role in dampening excessive inflammation (inflammaging) is beneficial for longevity rather than detrimental. The model inverted the logic: restraining chronic inflammation via Siglec-E's inhibitory signaling would be pro-longevity, not anti-longevity. The model's mechanistic framing about immune suppression impairing senescent cell clearance is speculative and not well-supported by the actual literature on Siglec-E in aging. The confidence of 0.62 is moderate but still represents a wrong prediction with flawed mechanistic reasoning.
Raw API responses
solver
{
"reasoning": "Siglec-E (Siglece) is an inhibitory receptor on innate immune cells (particularly neutrophils and macrophages) that binds sialic acid-containing glycans and delivers immunosuppressive signals via ITIMs. While this dampens acute inflammatory responses, Siglec-E's normal function suppresses immune surveillance and anti-pathogen responses, and its sialic acid-binding activity is exploited by tumors and pathogens to evade immune clearance. In the context of aging, chronic low-grade inflammation (inflammaging) is a hallmark, and Siglec-E's inhibitory role on innate immune cells can impair the clearance of senescent cells and damaged cellular debris, thereby permitting accumulation of pro-aging signals. Loss of Siglec-E function in mice has been associated with enhanced immune activation, suggesting its normal function restrains beneficial immune responses needed for tissue homeostasis in aging. Thus, the normal pro-inhibitory function of Siglec-E is predicted to be anti-longevity by blunting immune clearance mechanisms that counteract inflammaging and cellular senescence.",
"confidence": 0.62,
"key_pathways": [
"Siglec-ITIM inhibitory signaling in innate immunity",
"Sialic acid-mediated immune checkpoint regulation",
"Senescent cell immune clearance (efferocytosis)"
],
"mechanism_class": "chronic_inflammation",
"longevity_influence": "anti_longevity"
}advisor
{
"notes": "The model predicted anti_longevity while the ground truth is pro_longevity. The model's reasoning is internally consistent but leads to the wrong conclusion. Siglec-E is an inhibitory immune receptor, and the model argues that its immunosuppressive function impairs clearance of senescent cells and damaged debris, making it anti-longevity. However, the ground truth indicates Siglec-E is pro-longevity, likely because its role in dampening excessive inflammation (inflammaging) is beneficial for longevity rather than detrimental. The model inverted the logic: restraining chronic inflammation via Siglec-E's inhibitory signaling would be pro-longevity, not anti-longevity. The model's mechanistic framing about immune suppression impairing senescent cell clearance is speculative and not well-supported by the actual literature on Siglec-E in aging. The confidence of 0.62 is moderate but still represents a wrong prediction with flawed mechanistic reasoning.",
"failure_mode": "confident_wrong",
"answer_correct": false,
"mechanism_correct": false,
"reasoning_quality": 2,
"ground_truth_questionable": false
}